View in EDS PDF Full Text

Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.

Saved in:
Bibliographic Details
Title: Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
Authors: Perez M; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Chakraborty A; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Lau LS; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Mohammed NBB; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Dimitroff CJ; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Source: The British journal of dermatology [Br J Dermatol] 2021 Aug; Vol. 185 (2), pp. 294-301. Date of Electronic Publication: 2021 May 04.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2133
DOI:10.1111/bjd.19891